Canada Life’s Exponent EXPO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.86M Hold
28,546
﹤0.01% 1175
2025
Q4
$1.98M Sell
28,546
-8,605
-23% -$604K ﹤0.01% 1164
2025
Q3
$2.58M Sell
37,151
-671
-2% -$48K ﹤0.01% 1122
2025
Q2
$2.83M Buy
37,822
+1,188
+3% +$92.1K ﹤0.01% 1045
2025
Q1
$2.97M Sell
36,634
-4,241
-10% -$369K 0.01% 1025
2024
Q4
$3.64M Sell
40,875
-3,798
-9% -$383K 0.01% 994
2024
Q3
$5.15M Buy
44,673
+3,615
+9% +$378K 0.01% 848
2024
Q2
$3.9M Buy
41,058
+2,717
+7% +$245K 0.01% 951
2024
Q1
$3.17M Buy
38,341
+206
+0.5% +$17K 0.01% 1026
2023
Q4
$3.35M Buy
38,135
+1,071
+3% +$87.7K 0.01% 980
2023
Q3
$3.17M Buy
37,064
+1,375
+4% +$124K 0.01% 947
2023
Q2
$3.33M Sell
35,689
-4,028
-10% -$379K 0.01% 917
2023
Q1
$3.96M Sell
39,717
-18,473
-32% -$1.88M 0.01% 869
2022
Q4
$5.77M Sell
58,190
-3,087
-5% -$300K 0.02% 673
2022
Q3
$5.37M Buy
61,277
+9,594
+19% +$910K 0.02% 652
2022
Q2
$4.72M Buy
51,683
+6,126
+13% +$577K 0.01% 722
2022
Q1
$5.04M Buy
45,557
+63
+0.1% +$6.08K 0.01% 759
2021
Q4
$5.31M Buy
45,494
+84
+0.2% +$9.87K 0.01% 734
2021
Q3
$5.18M Buy
45,410
+467
+1% +$50.4K 0.01% 719
2021
Q2
$4.01M Buy
44,943
+384
+0.9% +$36K 0.01% 781
2021
Q1
$4.34M Sell
44,559
-6,279
-12% -$589K 0.01% 758
2020
Q4
$4.58M Sell
50,838
-7,232
-12% -$577K 0.01% 795
2020
Q3
$4.18M Sell
58,070
-5,230
-8% -$416K 0.01% 776
2020
Q2
$5.12M Sell
63,300
-4,974
-7% -$358K 0.01% 681
2020
Q1
$4.91M Buy
68,274
+4,219
+7% +$306K 0.01% 635
2019
Q4
$4.38M Buy
+64,055
New +$4.23M 0.01% 754
2019
Q3
Sell
-70,100
Closed -$4.1M 1491
2019
Q2
$4.1M Sell
70,100
-126
-0.2% -$7.17K 0.01% 807
2019
Q1
$4.05M Buy
70,226
+2,435
+4% +$132K 0.01% 715
2018
Q4
$3.17M Buy
67,791
+1,477
+2% +$74.1K 0.01% 791
2018
Q3
$3.56M Sell
66,314
-2,622
-4% -$134K 0.01% 827
2018
Q2
$3.33M Buy
68,936
+30
+0% +$1.38K 0.01% 868
2018
Q1
$2.71M Buy
68,906
+280
+0.4% +$10.6K 0.01% 958
2017
Q4
$2.44M Sell
68,626
-2,000
-3% -$73.4K 0.01% 1043
2017
Q3
$2.61M Sell
70,626
-4,686
-6% -$155K 0.01% 985
2017
Q2
$2.19M Buy
75,312
+2,334
+3% +$69.7K 0.01% 1090
2017
Q1
$2.17M Buy
72,978
+4,748
+7% +$138K 0.01% 1081
2016
Q4
$2.06M Sell
68,230
-2,176
-3% -$63.1K 0.01% 1074
2016
Q3
$1.8M Buy
70,406
+2,302
+3% +$60K 0.01% 1117
2016
Q2
$1.99M Buy
68,104
+61,964
+1,009% +$1.61M 0.01% 1020
2016
Q1
$156K Hold
6,140
﹤0.01% 1465
2015
Q4
$153K Buy
6,140
+2,752
+81% +$69.8K ﹤0.01% 1446
2015
Q3
$76K Hold
3,388
﹤0.01% 1885
2015
Q2
$76K Hold
3,388
﹤0.01% 2034
2015
Q1
$75K Hold
3,388
﹤0.01% 1952
2014
Q4
$70K Hold
3,388
﹤0.01% 1958
2014
Q3
$60K Hold
3,388
﹤0.01% 1964
2014
Q2
$63K Hold
3,388
﹤0.01% 1843
2014
Q1
$63K Hold
3,388
﹤0.01% 1654
2013
Q4
$66K Buy
+3,388
New +$64K ﹤0.01% 1627

Other funds holding EXPO

Canada Life's EXPO Position: Q1 2026 in Review

Canada Life held its Exponent (EXPO) position steady in Q1 2026 at 28,546 shares worth $1.86M. The position accounts for ﹤0.01% of the portfolio, ranked #1175.

Canada Life first reported a position in EXPO in Q4 2013 and has held it in 49 quarters since. The position peaked at $5.77M in Q4 2022. 360 funds tracked by Wall St. Rank hold EXPO as of Q1 2026.

  • Canada Life held 28,546 shares of Exponent worth $1.86M as of Q1 2026.
  • Canada Life left its Exponent share count unchanged in Q1 2026.
  • Exponent made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1175 holding.
  • Canada Life first reported a position in Exponent in Q4 2013 and has held it in 49 quarters since.
  • Canada Life's Exponent position peaked at $5.77M in Q4 2022.
  • 360 funds tracked by Wall St. Rank held Exponent as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.